Pfizer is advancing obesity science. New Phase 2b data... for our investigational GLP‑1 RA peptide show robust efficacy and favourable GI tolerability across weekly and monthly dosing, supporting our extensive pivotal program. Learn more: [link] #ADASciSessions #Obesity #GLP1 #ClinicalTrials #Innovation #Healthcareshow more

Today marks a significant moment for Pfizer Inc. with... the completion of our acquisition of Liate COHEN. Their highly differentiated candidates for obesity and cardiometabolic disease combined with Pfizer as a powerhouse in primary care, commercialization and manufacturing position us to reshape the treatment landscape. We’re not just participating in the obesity category. We aim to define it. Look forward to welcoming our new expert colleagues.show more

We’ve announced clinical trial clearances from both the FDA... and Health Canada for our investigational encapsulated cell therapy for the potential treatment of type 1 diabetes. Learn more:show more

Progress in non-muscle invasive bladder cancer (NMIBC) depends on... continued innovation in how the disease is treated and managed over time. As patients and healthcare providers navigate complex care decisions, ImmunityBio is advancing new therapeutic approaches designed to support improved outcomes. Learn more:show more

On this #WorldScienceDay, let’s celebrate the power of knowledge... and innovation that shapes a sustainable future. May science continue to guide us toward solutions for our planet’s greatest challenges—advancing progress, equity, and hope for generations to come. Happy World Science Day!show more

Unveiling our new brand logo! 🎉 This redesign reflects... our journey in advancing #innovation and excellence. Micron is #AheadoftheCurve, delivering next-gen memory and storage solutions that transform how the world uses information to enrich life for all.show more

NFA is live on Telegram. Dive into quests, earn... XP, and join our raffles for daily, weekly, and monthly rewards! Join now 👉show more

DeepSeek was developed for under $6 million. ChatGPT spent... $6 billion. The difference was an algorithmic breakthrough. TIG is home to DeepSeek-level breakthroughs across all of science. And today, we're unveiling our new vision for accelerating algorithmic innovation worldwide. The future of open science starts today ↓show more

“This is what 150lbs and 5’7 of obesity looks like,btw”

.@Genome_gov has selected Adam Phillippy to be our first... director of our new Center for Genomics and Data Science Research! Adam’s career involves building tools to analyze and assemble gene sequences.show more

🆕 Announcing #FortiPoints, a new universal points-based licensing program... that further simplifies acquisition and delivery across all our offerings. Learn how to get started today ➡️show more

The pandemic of mental illness and obesity.

🎉 Meet our newest AWS Heroes! Six exceptional leaders... making waves across the globe, driving community innovation, advancing AI solutions, and reshaping cloud development. Their work is inspiring the next generation of builders. Kristine Armiyants, Nadia Reyhani, Raphael Manke, Rowan El Shnnawy, Sangwoon (Chris) Park, Toshal Khawale Learn more: #AWSHeroes #AWSCommunity #AWSHeroshow more

PHASE 3: #Node Rental Onboarding! 🔥 We’ve successfully completed... all setup operations, and our Nodes are primed and ready for use! After extensive testing of both our platform and hardware, we’ve fine-tuned each node to ensure peak performance for their designated tasks. ✅ Phase 1: Setup ✅ Phase 2: Testing ☑️ ➤ Phase 3: Launch ☑️ Phase 4: Scaling For this phase we are focussed on customer onboarding, as well as monitoring the performance and energy use of our Nodes for future refinement. Our #NodeRental service officially goes live: 🗓 Wed 16th Oct | 5 PM UTCshow more

A new era of #GalaxyAI unfolds. Show your for... this post and get ready for updates on our #SamsungUnpacked livestream, featuring some surprise guests! Learn more:show more

Rapid innovation is reshaping data centers for efficience and... security says Stephen Mackey from Oakland University Watch our entire discussion here:show more

By 2035, obesity will affect 1.5 billion people, increasing... cardiovascular risk. Click to find out more about Rethink Obesity. #ADA2024show more

Even elementary schoolers are being put on popular weight-loss... drugs such as Wegovy. Doctors say that GLP-1 medications can prevent lifelong obesity and Type 2 diabetes in children—but there are some worries. 🔗show more